HR Execs on the Move

WaferGen Biosystems

www.wafergen.com

 
WaferGen Bio-systems, Inc. is an innovative life science company that offers innovative genomic solutions for clinical testing and research. The SmartChip MyDesign(TM) Real-Time PCR System is a high-throughput genetic analysis platform for profiling and validating molecular biomarkers via microRNA and mRNA gene expression profiling, as well as single nucleotide polymorphism (SNP) genotyping. The SmartChip TE(TM) System is a novel product offering for target enrichment geared towards clinical Next-Gen sequencing (NGS). The Company now also offers the Apollo 324(TM) product line used in library preparation for NGS. These three complementary technologies offer a powerful set of tools enabling more accurate, faster ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.wafergen.com
  • 7400 Paseo Padre Pkwy
    Fremont, CA USA 94555
  • Phone: 510.651.4450

Executives

Name Title Contact Details

Similar Companies

IRIDEX Corporation

IRIDEX Corporation is a worldwide leader in developing, manufacturing, marketing and selling innovative and cost-effective medical laser systems. The company has the largest global installed base of solid-state lasers and focuses on developing laser products that are clinically effective, reliable, portable, versatile, and affordable.

Centre Hospitalier Mount-Sina

Centre Hospitalier Mount-Sina is a CíÇte Saint-Luc, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Fortec Medical Inc

Fortec Medical Inc is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthMedia

HealthMedia is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Advanced Cardiac Therapeutics Inc

Advanced Cardiac Therapeutics, Inc. is a pre-commercial, medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB. AFIB is characterized by an irregular, often rapid heart rate that commonly causes poor systemic blood flow. The Company`s mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system. ACT`s technology is the only system in the world to leverage feedback from four unique capabilities: temperature sensing, low irrigation flow rates, high resolution EGM attenuation and contact sensing. The ACT system is not currently approved for commercial use.